Enovate Healthcare Ltd - Accounts to registrar (filleted) - small 22.3

REGISTERED NUMBER: 08471725 (England and Wales)

Unaudited Financial Statements for the Period 1 April 2021 to 30 September 2022

for

Enovate Healthcare Ltd

Page

Balance Sheet

1

CURRENT ASSETS

1,661

2,326

CREDITORS

Amounts falling due within one year

(6,075

)

(5,425

)

NET CURRENT LIABILITIES

(4,414

)

(3,099

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(4,414

)

(3,099

)

CAPITAL AND RESERVES

(4,414

)

(3,099

)

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Enovate Healthcare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

08471725

Registered office:

The Old Grange

Warren Estate

Lordship Road

Writtle

Essex

CM1 3WT

The company is not part of a group.

The current period ended 30 September 2022 covers a 18 month period and the comparative information covers an 12 month period, therefore the figures are not directly comparable.

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 2 (2021 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 September 2022.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 September 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 15 February 2023 and were signed on its behalf by:

M Walsh - Director